Skip to main content
v2026.11,858 entries · CC-BY 4.0

Editorial · CASRAI · AI and ML research outputs

OpenAI Rules Out a 2026 IPO, Citing Safety Obligations

OpenAI CEO Sam Altman ruled out a 2026 IPO, tying the delay to AI safety and alignment work and to a nonprofit/for-profit structure he says lets the company make decisions public markets would not tolerate.

Published 21 Sept 2026· 6 minute read

Ask CASRAI · free to try

Ask about this story

Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.

Ask CASRAI answers research-administration questions and cites the passages behind every claim. When our sources don't cover a question, it says so.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.

CASRAI is the reference for research administration — bookmark it for the next question.

Short answer: OpenAI CEO Sam Altman has ruled out taking the company public in 2026, saying the reason is safety and alignment work he considers unfinished, and a hybrid nonprofit/for-profit governance structure he says lets OpenAI make decisions “not obviously in the interest of our business and our shareholders” — a freedom he argues public-market scrutiny would constrain. Last verified: September 20, 2026. This article is sourced to two independent reports of the same remarks — Investing.com (via Yahoo Finance, published September 12, 2026) and Forkast News (via Yahoo Finance, published September 19, 2026) — not to OpenAI’s own newsroom, since OpenAI has not published a statement of its own on the decision as of this writing.

What Altman said, in atomic facts

  • Who: Sam Altman, CEO of OpenAI.
  • What: ruled out a 2026 initial public offering for OpenAI.
  • Quote — timing: “I actually think that, given everything happening with safety, right now would be an ill-advised moment to go public.”
  • Quote — readiness: “We got a lot of stuff to do, like meeting this moment of what is going to be required for safety and alignment.”
  • Quote — why structure matters: “We have put up with this incredibly complicated structure for a long time, and this moment that we’re in now is kind of why. We need to be able to make decisions that are not obviously in the interest of our business and our shareholders.”
  • Structure referenced: OpenAI’s hybrid nonprofit/for-profit corporate structure, which Altman frames as the mechanism that currently lets the company prioritize its stated mission over shareholder interest — a latitude he says an IPO and public-market scrutiny would narrow.
  • Prior timeline reporting: earlier reporting (The New York Times, June 2026) had OpenAI weighing a possible IPO around 2027; Altman’s September remarks do not commit to any specific future date, only that 2026 is out.
  • Sourcing: Investing.com, “OpenAI CEO Sam Altman Rules Out 2026 IPO as Going Public Now Would Be ‘Ill-Advised’,” via Yahoo Finance, published September 12, 2026, byline Navamya Acharya; and Forkast News, “OpenAI Rules Out 2026 IPO, Citing Safety Obligations,” via Yahoo Finance, published September 19, 2026, byline Lena Park. Both report the same remarks; CASRAI has not independently verified them against an OpenAI-published transcript, since none has been published.

A cross-lab contrast: governance through corporate structure vs. governance through disclosure

Altman’s framing is worth reading next to how CASRAI has covered the other large US frontier lab’s recent governance moves, because the two labs are reaching for different levers. OpenAI’s argument here is structural: keep the current nonprofit/for-profit hybrid, and defer the discipline an IPO would impose, specifically so the company can make safety-motivated calls that might not serve shareholders. Anthropic’s recent moves have instead been about disclosure and outside spending: CASRAI covered Anthropic’s new transparency metrics on the pace of frontier AI development, published September 17, 2026, which publish three self-reported figures — including how much of Anthropic’s own AI R&D is performed by AI — for outside scrutiny while Anthropic remains privately held. CASRAI also covered Anthropic and Accenture’s matched $1 billion commitment to scale third-party AI model evaluation, a spending-and-partnership lever rather than a structural one. None of this is a like-for-like comparison — OpenAI’s move is a decision about when (not whether) to open itself to public markets, while Anthropic’s are ongoing disclosure and evaluation commitments made as a private company — but both are, in their own way, arguments about what a frontier lab owes outside observers before or instead of an IPO, and both are exactly the kind of institutional commitment NIKOLAI’s governance track exists to catalogue (see below).

Where this fits in CASRAI’s NIKOLAI project

NIKOLAI is CASRAI’s own frontier-AI-safety dictionary of elements — an independent, unendorsed reference work, not a standard any lab, evaluator, or regulator has adopted or confirmed. Its N9 track, “Commitments and governance,” exists to catalogue exactly this kind of institutional decision. One N9 element is directly relevant here, verified against its live element page before being quoted: Accountable Decision-Maker and Sign-Off, defined as “a named role (and, where published, the named person) who makes or approves a threshold determination, risk-acceptance decision, deployment decision, redaction, or framework change, together with the approval record itself — what was approved, by whom, and when.”

Altman’s stated reason for keeping OpenAI’s current structure — that it lets the company “make decisions that are not obviously in the interest of our business and our shareholders” — is, read plainly, a claim about who the accountable decision-maker is and what constrains their sign-off authority: under OpenAI’s nonprofit-controlled structure that decision-maker can weigh safety and mission ahead of shareholder return, a latitude Altman argues an IPO would narrow by adding public shareholders with fiduciary claims on those same decisions. This is not an instance of the element as NIKOLAI’s live mapping table currently records it for OpenAI — that table catalogues OpenAI’s existing named approval roles and processes, not hypothetical ones under a structure OpenAI has chosen not to adopt. What Altman’s remarks describe is better read as a shadow mapping: CASRAI’s own, unendorsed reading of how a corporate-structure choice (stay privately controlled by a nonprofit board vs. go public) changes who counts as the accountable decision-maker for a safety-motivated call, and how directly that person can be pulled toward shareholder interest instead. As with every NIKOLAI crosswalk row, this is CASRAI’s own independent, unendorsed reading of a public source — not a mapping OpenAI has confirmed, adopted, or endorsed.

Frequently Asked Questions

Did OpenAI rule out an IPO entirely, or just for 2026?

Just 2026. Altman’s own words were “I would say not 2026,” and earlier reporting (The New York Times, June 2026) had pointed to a possible 2027 listing; his September remarks don’t commit to 2027 or any other specific date, only that 2026 is off the table.

What reason did Sam Altman give for the delay?

Two, stated together: that OpenAI still has unfinished work “required for safety and alignment,” and that the company’s current nonprofit/for-profit structure lets it make decisions that don’t obviously serve shareholders — a latitude he says going public now would be “ill-advised” given that unfinished safety work.

Is this an OpenAI-published statement?

No. As of this writing OpenAI has not published its own account of these remarks; this article is sourced to two independent news reports (Investing.com/Yahoo Finance, September 12, 2026; Forkast News/Yahoo Finance, September 19, 2026) that attribute the same quotes to Altman.

Is NIKOLAI’s crosswalk here an official OpenAI position?

No. NIKOLAI is CASRAI’s own independent, unendorsed reference project. The Accountable Decision-Maker and Sign-Off tie-in in this article is CASRAI’s own shadow mapping of Altman’s public remarks against NIKOLAI’s N9 track — OpenAI has not confirmed, adopted, or endorsed it.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →